OpenVSafe by OpenVAERS
Search V-safe

CCV-15496-14877

2 vaccinations 10 coded responses 22 check-ins 10 free-text entries 8 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
265 / WV
Registered
2020-12-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
L42-19042-29119 Child or adolescent in my care · Female · 2021-11-12
KRQ-20600-20605 Child or adolescent in my care · Male · 2022-06-24

Timeline

  1. 2020-12-18
    Registered in v-safe
  2. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-18
    Health check-in — day 0, dose 1
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  4. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2020-12-19
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  6. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  7. 2020-12-20
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  8. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  9. 2020-12-21
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  10. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  11. 2020-12-22
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  12. 2020-12-27
    Health check-in — day 7, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  13. 2020-12-27
    Report sent to call center — day 7, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  14. 2021-01-02
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  15. 2021-01-08
    Survey response — day 21, dose 1
    MedDRA: Abdominal discomfort, Chest pain, Chills, Cough, Dizziness, Dyspnoea exertional, Fatigue, Feeling abnormal, Heart rate increased — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Gi distress, burning chest pain, dizziness, brain fog, fatigue, cough, elevated heart rate with minimal activity, dyspnea with exertion, chills.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-08
    Report sent to call center — day 21, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  17. 2021-01-18
    Survey response — day 28, dose 1
    MedDRA: Arrhythmia, Chest discomfort, Chest pain, Dyspnoea, Fatigue, Headache, Sleep disorder — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Heart arrhythmia, chest pain, chest tightness. Fatigue. Headache. Shortness of breath. Inability to sleep.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-01-18
    Report sent to call center — day 28, dose 1
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  19. 2021-01-20
    Dose 2 — Pfizer-BioNTech
  20. 2021-01-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  21. 2021-01-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hypoaesthesia oral, Paraesthesia oral — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work
    Free text: Tingling/numb tongue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-01-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain, Hypoaesthesia oral — Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Tongue numbness. Chest pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-01-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Hypoaesthesia oral — Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Tongue numbness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-01-26
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain, Hypoaesthesia oral — Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Numb tongue. Chest pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-01-27
    Survey response — day 7, dose 2
    MedDRA: Arrhythmia, Chest pain, Hypoaesthesia oral — Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Tongue numbness. Chest pain. Heart arrhythmia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-02-04
    Survey response — day 14, dose 2
    MedDRA: Tachycardia — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Tachycardia
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-02-04
    Report sent to call center — day 14, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  28. 2021-02-10
    Survey response — day 21, dose 2
    MedDRA: Chest pain — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Chest pain.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  29. 2021-02-12
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  30. 2021-02-17
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  31. 2021-02-25
    Survey response — day 35, dose 2
    MedDRA: Chills, Headache, Pain, Pyrexia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities
    Free text: Fever, chills,body aches, headache.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  32. 2021-03-03
    Health check-in — day 42, dose 2
    Feeling: Poor
    Adult check-in
  33. 2021-04-22
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  34. 2021-07-21
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-20Pfizer-BioNTech

Call center

8 call center cases

8 successful

See the call center timeline

Free text

Release 1 — day 21, dose 1

2021-01-08

Symptoms: Gi distress, burning chest pain, dizziness, brain fog, fatigue, cough, elevated heart rate with minimal activity, dyspnea with exertion, chills.

Release 2 — day 28, dose 1

2021-01-18

Symptoms: Heart arrhythmia, chest pain, chest tightness. Fatigue. Headache. Shortness of breath. Inability to sleep.

Release 2 — days 1–6 daily, dose 2

2021-01-23

Systemic reaction (other): Tingling/numb tongue

2021-01-24

Systemic reaction (other): Tongue numbness. Chest pain

2021-01-25

Systemic reaction (other): Tongue numbness

2021-01-26

Systemic reaction (other): Numb tongue. Chest pain

Release 2 — day 7, dose 2

2021-01-27

Systemic reaction (other): Tongue numbness. Chest pain. Heart arrhythmia

Release 3 — day 14, dose 2

2021-02-04

Symptoms: Tachycardia

Release 4 — day 21, dose 2

2021-02-10

Symptoms: Chest pain.

Release 4 — day 35, dose 2

2021-02-25

Symptoms: Fever, chills,body aches, headache.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal discomfort ✓ ✓ ✓
SDArrhythmia ✓ ✓ ✓
SDChest discomfort ✓ ✓ ✓
SDChest pain ✓ ✓ ✓
SDChills ✓ ✓ ✓
SDCough ✓ ✓ ✓
SDDizziness ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDDyspnoea exertional ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDFeeling abnormal ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHeart rate increased ✓ ✓ ✓
SDPain ✓ ✓ ✓
SDPyrexia ✓ ✓ ✓
SDSleep disorder ✓ ✓ ✓
SDTachycardia ✓ ✓ ✓
SROArrhythmia ✓ ✓ ✓
SROChest pain ✓ ✓ ✓
SROHypoaesthesia oral ✓ ✓ ✓
SROParaesthesia oral ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release